Shandong Shanda Wit Science and Technology Co Ltd (000915)

Currency in CNY
24.41
-0.46(-1.85%)
Closed·
Advertisement
High dividend Yield
000915 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
24.3925.03
52 wk Range
24.1136.70
Key Statistics
Bid/Ask
24.40 / 24.41
Prev. Close
24.87
Open
24.76
Day's Range
24.39-25.03
52 wk Range
24.11-36.7
Volume
1.98M
Average Volume (3m)
3.01M
1-Year Change
-25.0767%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
000915 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
0.00
Downside
-100.00%
Members' Sentiments
Bearish
Bullish
ProTips
High shareholder yield

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 0.00
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
23/04/2026
EPS / Forecast
0.47 / --
Revenue / Forecast
412.27M / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.97%
Dividend Yield
10.05%
Industry Median 1.78%
Annualised payout
2.50
Paid unevenly
5-Years Growth
+48.17%
Growth Streak

Compare 000915 to Peers and Sector

Metrics to compare
000915
Peers
Sector
Relationship
P/E Ratio
12.3x18.3x−0.4x
PEG Ratio
−0.990.850.00
Price/Book
1.9x2.3x2.6x
Price / LTM Sales
2.8x3.4x3.0x
Upside (Analyst Target)
-46.0%51.9%
Fair Value Upside
Unlock16.3%9.4%Unlock

Shandong Wit Dyne Health Co.,Ltd. engages in the pharmaceutical business in China. Its medical products include azithromycin granules, glycyrrhizin zinc granules, compound calcium carbonate, vitamin AD drops, iprastat tablets, valsartan hydrochlorothiazide gel, roxithromycin, rosiglitazone tartrate tablets, and glimepiride tablets. The company also provides dextran iron granules, oral rehydration salts, montmorillonite powder, azithromycin granules, rifaximin dry suspension, and dimercaptosuccinic acid capsules. In addition, it offers information products, such as DLP splicing display units, LCD splicing display units, image stitching processors, communication products, and industrial automation control products; and crystal products. The company is also involved in research, development, production, and sales of children's medicines and health products, as well as leasing and property management services. Shandong Wit Dyne Health Co.,Ltd. was founded in 1993 and is based in Jinan, China.

Employees
1719
Market
China

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
28.05M11.97%697.52M
Other Institutional Investors
72.30M30.85%1.80B
Public Companies & Retail Investors
133.99M57.18%3.33B
Total
234.33M100.00%5.83B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Shandong State-owned Assets Investment Holdings Co., Ltd.22.00%51,544,3401,281,908
China Asset Management Co. Ltd.3.35%7,854,349195,338

People Also Watch

85.89
300896
-1.14%
33.33
603288
-2.26%
105.08
600809
-2.38%

FAQ

What Is the Shanda Wit Sci A (Shenzhen: 000915) Share Price Today?

The Shanda Wit Sci A stock price today is 24.41 CNY.

What Stock Exchange Does Shanda Wit Sci A (000915) Trade On?

Shanda Wit Sci A is listed and trades on the Shenzhen Stock Exchange.

What Is the Ticker (Stock Symbol) for Shanda Wit Sci A?

The stock symbol (also called a 'ticker') for Shanda Wit Sci A is "000915."

Does Shanda Wit Sci A Pay Dividends? What’s The Current 000915 Dividend Yield?

Yes, 000915 Pays Dividends to its Shareholders. The current Shanda Wit Sci A dividend yield is 10.24%.

What Is the Current Shanda Wit Sci A Market Capitalisation?

As of today, Shanda Wit Sci A (Shenzhen: 000915) market cap is 5.72B CNY.

What Is Shanda Wit Sci A's (000915) Earnings Per Share (TTM)?

The Shanda Wit Sci A EPS is currently 1.97 (Trailing Twelve Months).

When Is the Next Shanda Wit Sci A Earnings Date?

Shanda Wit Sci A's next earnings report will be released on 21/08/2026.

Is 000915 a Buy or Sell From a Technical Analyst Perspective?

Based on today's Shanda Wit Sci A moving averages and other technical indicators, the daily buy/sell signal for 000915 stock is Strong Sell.

How Many Times Has Shanda Wit Sci A Stock Split?

Shanda Wit Sci A has split 2 times. (See the 000915 stock split history page for full effective split date and price information.)

How Many Employees Does Shanda Wit Sci A Have?

Shanda Wit Sci A has 1719 employees, based on their latest Companies House report.

What is the current trading status of Shanda Wit Sci A (Shenzhen: 000915)?

As of 09/07/2026, Shanda Wit Sci A (000915) is trading at a share price of 24.41 CNY, with a previous close of 24.87 CNY. The stock has fluctuated within a day range of 24.39 CNY to 25.03 CNY, while its 52-week range spans from 24.11 CNY to 36.70 CNY.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.